BMS just signed a $15.2 billion drug deal with China’s biggest pharma company. The patent cliff left it no choice.
Bristol Myers Squibb Signs $15.2 Billion Drug Deal with China’s Hengrui as Patent Cliff Looms
May 12, 2026 – 9:22 pm
TL;DR:
Bristol Myers Squibb has sig…